// App-Quantinova.ai

: Alveolar Dead Space Fraction and Respiratory System Compliance Predict the Effect of Extracorporeal CO2 Removal on Driving Pressure: Foundation for a Precision Medicine Strategy

Researchers

Presenter

  • E. C. Goligher

Principal Investigators

  • A. Combes

  • D. Brodie

  • M. B. P. Amato

  • V. Fanelli

  • T. Pham

  • V. M. Ranieri

  • A. S. Slutsky

  • ECMONet

Medical Centers

  • Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada,

  • Rea Medicale, Paris 75013, France,

  • Columbia Univ Coll of Phys & Surg, New York, NY, United States,

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • University of Turin, Turin, Italy

  • Interdepartmental Critic, St Michael's Hospital, Toronto, France,

  • Univ of Turin, Turin 10100, Italy,

  • Research, St Michaels Hospital, Toronto, ON, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved